Correspondence 0001558370-24-001252 from CytoDyn Inc. (CYDY)
CytoDyn Inc.
Date: Feb. 15, 2024 · CIK: 0001175680 · Accession: 0001558370-24-001252
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276912
Letter
CYTODYN INC.
February 15, 2024
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549
Attention: Alan Campbell
Re:CytoDyn Inc. Registration Statement on Form S-1 File No. 333-276912 Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1 filed on February 7, 2024 (File No. 333-276912) (the “Registration Statement”) so that the Registration Statement shall become effective at noon Eastern Time on February 21, 2024, or as soon as possible thereafter.
We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing.
If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you.
Very truly yours,
CYTODYN INC.
Show Raw Text
CORRESP 1 filename1.htm CYTODYN INC. February 15, 2024 VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Alan Campbell Re:CytoDyn Inc. Registration Statement on Form S-1 File No. 333-276912 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1 filed on February 7, 2024 (File No. 333-276912) (the “Registration Statement”) so that the Registration Statement shall become effective at noon Eastern Time on February 21, 2024, or as soon as possible thereafter. We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing. If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you. Very truly yours, CYTODYN INC. By: /s/ Mitchell Cohen____ Mitchell Cohen Interim Chief Financial Officer cc: Mary Ann Frantz, Miller Nash LLP